Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Translational neuroprotection research in glaucoma: a review of definitions and principles|
|Citation:||Clinical and Experimental Ophthalmology, 2012; 40(4):350-357|
|Publisher:||Blackwell Publishing Asia|
|Robert J Casson, Glyn Chidlow, Andreas Ebneter, John PM Wood, Jonathan Crowston and Ivan Goldberg|
|Abstract:||The maintenance of vision, through prevention and attenuation of neuronal injury in glaucoma, forms the basis of current clinical practice. Currently, the reduction of intraocular pressure is the only proven method to achieve these goals. Although this strategy enjoys considerable success, some patients progress to blindness; hence, additional management options are highly desirable. Several terms describing treatment modalities of neuronal diseases with potential applicability to glaucoma are used in the literature, including neuroprotection, neurorecovery, neurorescue and neuroregeneration. These phenomena have not been defined within a coherent framework. Here, we suggest a set of definitions, postulates and principles to form a foundation for the successful translation of novel glaucoma therapies from the laboratory to the clinic.|
|Keywords:||glaucoma; glaucoma medical therapy; glaucoma medication.|
|Rights:||© 2011 The Authors|
|Appears in Collections:||Opthalmology & Visual Sciences publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.